News
News Center
2020-02-25
On February 21, the Joint Prevention and Control Mechanism of the State Council for the COVID-19 Epidemic held a press conference. At the briefing, Vice Minister of Science and Technology Xu Nanping announced that four critically ill COVID-19 patients have now been discharged from the hospital after receiving stem-cell therapy, and clinical trials will soon be expanded to further evaluate its effectiveness.
+
2020-02-25
How are stem cells overcoming the novel coronavirus?
Currently, the fight against the novel coronavirus pneumonia epidemic has entered a critical phase, with cutting-edge technologies such as precision medicine and stem-cell research stepping up to join the battle against the outbreak.
+
2020-02-20
Jiuzhitang Maker's stem-cell-based new drug receives approval for clinical trials
Great news! Jiuzhitang Maker's stem-cell-based new drug has received approval for clinical trials! This marks the first time the Center for Drug Evaluation (CDE) under China’s National Medical Products Administration has approved a clinical trial using imported stem cells, as well as the first trial employing bone-marrow-derived mesenchymal stem cells. It’s also the first-ever clinical study to explore stem cells as a treatment for major neurological conditions.
+
2020-02-03
New trends, new opportunities — Join us and let your dreams take flight together!
Jiuzhitang Maker is now recruiting distributors nationwide—join us today!
+
2020-01-28
At Zhejiang University First Hospital, we’ve been using a new approach called stem cell therapy in the treatment of H7N9 avian influenza. Early findings suggest that stem cells show promising results in addressing lung infections and pulmonary fibrosis in avian flu patients. As a result, the hospital’s ethics committee has already approved this innovative treatment, and we’re now preparing to apply it to severe cases of the novel coronavirus.
+
2020-01-23
As the vibrant 2020 Spring Festival approaches, Zhang Quancheng, Chairman of Meike Company, and Gao Yansong, General Manager, extend their warmest wishes on behalf of everyone at Jiuzhitang Maker! We sincerely thank each and every friend and family member who has shown care, support, affection, and attention to the growth of Jiuzhitang Maker. Wishing you all a joyful and prosperous New Year!
+
2020-01-23
Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. recently received significant funding from Beijing's major science and technology project. The company's proposed project, "Preclinical Study of Human Bone Marrow Mesenchymal Stem Cells for the Treatment of Acute Stroke," has been officially approved (Project No. Z191100001519004).
+
2020-01-23
On January 14, 2020, the Zhongguancun Science Park Administrative Committee announced the ninth batch of Golden Seed Enterprise名单, and Jiuzhitang Maker was proudly listed!
+
2020-01-01
Looking back at 2019, Meike took every step with solid confidence and strength.
We're on the road.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy